Can Naltrexone Cause Alcohol Withdrawal?

Naltrexone does not cause alcohol withdrawal. It blocks opioid receptors in the brain, which is an entirely different system from the one responsible for alcohol withdrawal symptoms. Alcohol withdrawal is driven by changes in the brain’s GABA and glutamate signaling after prolonged heavy drinking, and naltrexone has no direct effect on either of those pathways. The confusion is understandable, though, because naltrexone has a well-documented ability to trigger severe withdrawal in people dependent on opioids, and its side effects can look a lot like mild withdrawal symptoms to someone who doesn’t know the difference.

How Alcohol Withdrawal Actually Happens

Alcohol enhances the activity of GABA, the brain’s main inhibitory neurotransmitter, while simultaneously dampening glutamate, its main excitatory one. Over months or years of heavy drinking, the brain compensates by dialing down its own GABA activity and ramping up glutamate. When alcohol is suddenly removed, that compensatory state is exposed: the brain is left in an overexcited, under-inhibited condition. The result is the spectrum of alcohol withdrawal, from anxiety and tremors to seizures and, in the worst cases, delirium tremens.

Ethanol directly disrupts GABAergic signaling, and the severity of that disruption depends on how much and how long someone has been drinking.¹ Roughly half of people with an alcohol use disorder will experience some degree of withdrawal when they cut back or stop.² The drugs used to manage acute withdrawal, most commonly benzodiazepines, work precisely because they act on the GABA system. Naltrexone does not touch that system in any meaningful way.

What Naltrexone Actually Does in the Brain

Naltrexone is a competitive antagonist at mu-opioid receptors. In plain terms, it parks itself in the receptor and prevents the brain’s natural opioids (endorphins) from binding and producing their usual pleasurable signal. This matters for alcohol use because drinking triggers endorphin release, which feeds into the dopamine reward circuit. By blocking that chain of events, naltrexone takes the “buzz” out of drinking: you can still drink, but the reinforcing pleasure is blunted.³

Research in animal models has shown that naltrexone interferes with ethanol-induced stimulation of the mesolimbic dopamine pathway, which is the brain’s primary reward highway. Specifically, it attenuates the changes in dopamine-related enzyme activity in the ventral tegmental area that alcohol normally triggers.⁴ This mechanism reduces the reinforcing “want” for alcohol over time, but it doesn’t create the kind of neurochemical emergency that withdrawal represents. The GABA-glutamate imbalance that drives withdrawal is simply not in naltrexone’s wheelhouse.

Why People Confuse Naltrexone Side Effects with Withdrawal

Naltrexone’s side-effect profile looks uncomfortably similar to mild alcohol withdrawal on paper. Nausea, headache, dizziness, fatigue, anxiety, and trouble sleeping are all common complaints in the first days to weeks of starting naltrexone. A person who has recently stopped drinking and then begins naltrexone may reasonably wonder whether the medication is making their withdrawal worse or even causing a new round of it.

The distinction is important: these are pharmacological side effects of blocking opioid receptors, not signs of a dangerous withdrawal syndrome. Endogenous opioids play a role in mood regulation, pain modulation, and gut function. When you block those receptors, some people feel temporarily off, with low mood, GI discomfort, and general malaise. These effects tend to settle within one to two weeks and rarely require stopping the medication. They are not the same thing as the GABA-driven hyperexcitability of true alcohol withdrawal, and they do not carry the same risks. No one develops seizures or delirium from naltrexone side effects alone.

Clinicians sometimes note that patients confuse these side effects with withdrawal, especially when naltrexone is started shortly after detox. Part of the issue is timing: many guidelines recommend starting naltrexone within a few days of completing detox, and the tail end of protracted withdrawal can overlap with the early side-effect window of the medication. Telling the two apart requires medical judgment, but the key reassurance is that naltrexone is not adding fuel to the withdrawal fire.

The Opioid Withdrawal Trap

Where naltrexone genuinely does cause withdrawal is in people with active opioid dependence. This is where the medication’s reputation gets tangled with the alcohol question. If someone who is physically dependent on opioids, whether heroin, fentanyl, oxycodone, or any other opioid, takes naltrexone before those drugs have fully cleared their system, the result is precipitated withdrawal. Naltrexone rips the opioids off their receptors, and withdrawal hits fast and hard.

A study of 132 patients who experienced naltrexone-precipitated opioid withdrawal documented a grim symptom profile: agitation in over 96% of cases, altered consciousness in nearly 39%, nausea in 28%, vomiting in 27%, abdominal pain in about 24%, and diarrhea in roughly 17%.⁵ Agitation was so severe it was described as the most difficult symptom to manage. This is a real medical emergency, and it is entirely different from alcohol withdrawal in its mechanism. Naltrexone causes opioid withdrawal by directly displacing opioids from their receptors. It does not cause alcohol withdrawal because alcohol does not sit on opioid receptors in the first place.

This distinction matters enormously for people who use both alcohol and opioids, which is not uncommon. Someone being treated for alcohol use disorder who also has undisclosed or unrecognized opioid dependence could be thrown into precipitated opioid withdrawal by naltrexone. The symptoms, including agitation, nausea, sweating, muscle pain, and rapid heart rate, can look almost identical to severe alcohol withdrawal. Without a careful history and often a urine drug screen, a clinician could mistake one for the other. This overlap is one of the reasons polysubstance use complicates naltrexone prescribing.

Why Doctors Wait Until After Detox

Standard clinical practice calls for completing alcohol detoxification before starting naltrexone. This isn’t because naltrexone would make alcohol withdrawal worse; it’s because the medication works best as a relapse-prevention tool, and starting it during acute withdrawal doesn’t make pharmacological sense. The FDA-approved extended-release injectable formulation of naltrexone is specifically indicated for patients who are able to abstain from alcohol before treatment initiation.⁶

In practice, however, many patients never make it through the gap between detox and the first naltrexone dose. A hospital-based quality improvement project found that before implementing a systematic naltrexone initiation protocol, only about 1.6% of patients hospitalized for alcohol detox were even counseled about the medication. After implementing educational algorithms and structured evaluation, the counseling rate jumped to over 63% and prescribing rose to about 28%.⁷ The reason this required a dedicated initiative is telling: clinicians were focused on managing the acute crisis and often didn’t bridge patients to relapse-prevention pharmacotherapy before discharge. The “wait until after detox” rule, while sound, sometimes becomes “never start at all.”

There is also a more flexible approach. Some evidence supports using naltrexone while a person is still actively drinking, particularly for people who are not willing or able to go through formal detox first. Clinical trials have found that this approach, sometimes called the Sinclair Method when naltrexone is taken specifically before drinking occasions, is both safe and effective.⁸ In this context, the goal isn’t to trigger abstinence overnight but to gradually reduce the brain’s learned association between drinking and pleasure. Even here, naltrexone does not provoke withdrawal symptoms. The person continues to drink, just with diminished reward.

Protracted Withdrawal and What Naltrexone Cannot Fix

Acute alcohol withdrawal typically resolves within a week, but a subtler form called protracted withdrawal can linger for weeks or months. Symptoms include persistent anxiety, sleep disruption, low mood, irritability, and difficulty concentrating. These are thought to stem from the same GABA-glutamate remodeling that causes acute withdrawal, just at a lower, slower-burning intensity.

Here is where naltrexone’s limitations become clear. Because protracted withdrawal symptoms are rooted in GABA and glutamate system dysregulation, naltrexone, along with other opioid-targeted medications and disulfiram, may not effectively suppress them.² This is an underappreciated point. People starting naltrexone in the weeks after detox sometimes report feeling anxious or sleeping poorly and blame the medication. In many cases, the real culprit is protracted withdrawal running its course underneath the naltrexone, which is simply doing a different job. Recognizing protracted withdrawal as a distinct phenomenon matters for treatment planning: it might call for different pharmacological support, such as medications that act on the GABA or glutamate systems, rather than adjusting or stopping naltrexone.

Acamprosate, the other major medication approved for alcohol relapse prevention, works through a completely different mechanism. Its primary effect appears to involve dampening the glutamate overactivity that contributes to both acute and protracted withdrawal.³ This makes it theoretically better suited for calming the neurological aftershocks of withdrawal, while naltrexone is better suited for reducing the rewarding pull of alcohol itself. Some treatment plans use both together.

Negative Mood Effects and the Kappa-Opioid Connection

There’s a wrinkle in naltrexone’s profile that deserves mention because it sometimes gets mistaken for a withdrawal effect. The brain’s opioid system has multiple receptor types, and while naltrexone primarily blocks mu-opioid receptors, it also has activity at kappa-opioid receptors. The kappa system is involved in what researchers call “negative affect,” the low mood, anxiety, and general emotional discomfort that heavy drinkers often feel between drinking episodes and especially during withdrawal.

Research has identified kappa-opioid receptors and their natural ligands, dynorphins, as playing a role in the anxious, dysphoric state that accompanies alcohol withdrawal.⁹ Naltrexone’s interaction with these receptors is complicated. Blocking kappa receptors could theoretically reduce some of the emotional misery of early sobriety, but mu-receptor blockade simultaneously dampens the brain’s endorphin-driven positive feelings. The net effect for some people starting naltrexone is a period of emotional flatness or low-grade dysphoria that feels suspiciously like the psychological component of withdrawal. It isn’t, mechanistically, but distinguishing “my brain’s reward system is being blocked by a medication” from “my brain is readjusting to life without alcohol” is not something you can feel from the inside.

Interactions with Benzodiazepines During Detox

Because benzodiazepines are the standard treatment for acute alcohol withdrawal, it’s worth knowing how naltrexone interacts with them if there’s any overlap. A study examining the co-administration of naltrexone and diazepam found that naltrexone altered both the subjective and pharmacokinetic effects of the benzodiazepine. Participants on naltrexone reported higher levels of negative mood states like sedation, fatigue, and anxiety, while positive effects such as friendliness and liking the drug’s effects were dampened. Naltrexone also delayed the time it took diazepam to reach peak blood levels, stretching it from about 75 minutes to 135 minutes.¹⁰

This is another potential source of patient confusion. If someone is tapering off benzodiazepines used during detox while simultaneously starting naltrexone, the naltrexone may be changing how the benzodiazepine feels and works, potentially making the taper feel rougher than it would otherwise. That uncomfortable experience could easily be misattributed to naltrexone “causing withdrawal.” It’s really a drug interaction affecting how the detox medication performs, not naltrexone generating withdrawal on its own.

Genetics and Variable Responses

Not everyone responds to naltrexone the same way, and genetic variation helps explain why some people seem to do well on it while others report feeling awful. A clinical trial examining genetic predictors of naltrexone response found that the drug’s effectiveness in reducing heavy drinking days varied significantly based on combinations of opioid and dopamine gene variants. Carriers of the OPRM1 G allele (a variant of the mu-opioid receptor gene) who also carried certain dopamine transporter or COMT gene variants showed the strongest benefit from naltrexone, with moderate-to-large effect sizes compared to placebo.¹¹

The practical implication is that a person whose genetic makeup doesn’t align well with naltrexone’s mechanism may experience the side effects, the emotional blunting, the nausea, the general discomfort, without getting much benefit in return. For that person, the experience of taking naltrexone feels like pure downside, and it would be natural to describe it as feeling like withdrawal. Pharmacogenomic testing is becoming more available and could eventually help clinicians identify who is most likely to benefit versus who might do better on a different medication entirely. For now, though, most prescribing is still trial-and-error.

When Naltrexone Gets Blamed for Something Else

The pattern across all these scenarios is the same: something uncomfortable is happening, and naltrexone is the newest variable in the picture, so it takes the blame. Sometimes it’s protracted withdrawal running underneath the medication. Sometimes it’s the overlap between pharmacological side effects and withdrawal symptoms. Sometimes it’s an unrecognized opioid dependence triggering genuine precipitated withdrawal that gets labeled as alcohol-related. And sometimes it’s the interaction between naltrexone and benzodiazepines during or shortly after detox.

None of these scenarios involve naltrexone actually triggering the neurochemical cascade that defines alcohol withdrawal. That cascade requires the removal of alcohol from a GABA-dependent brain, and naltrexone has nothing to do with it. If you’re prescribed naltrexone for alcohol use disorder and you feel lousy in the first couple of weeks, there’s a conversation worth having with your prescriber about whether what you’re feeling is a side effect, lingering withdrawal, or something else. But the one thing you don’t need to worry about is naltrexone creating a new withdrawal episode out of thin air.